THE ACCC-approved merger of generic medicines giants Arrow Pharmaceuticals and Apotex Australia & NZ last month (PD 21 Sep) has created a challenge in the creation of a single joint name that reflects the original company nomenclature.
While obvious choices for the new company might look like Arrotex or Arrowtex, companies with those names already exist, in the form of a US wholesale building supply firm and a New York Stock Exchange-listed textile company respectively.
A recent Blooms The Chemist conference saw the new company present and toss some ideas around according to an un-named Blooms member pharmacist.
Arrotex Pharma or Arrotex Pharmaceuticals are unconfirmed front runners but the final decision still remains to be announced.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Oct 18
